Ortin Laboratories

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue1.491.570.270.140.30
Expenses1.671.551.372.943.49
EBITDA-0.030.19-0.90-2.61-3.05
EBIT-0.090.13-0.96-2.67-3.10
Profit Before Tax-0.200.02-1.10-2.81-3.17
Net Profit-0.200.02-1.12-2.79-4.14
Financial Ratios
Operating Profit Margin-4.11%12.10%-346.15%-1,857%-2,179%
Net Profit Margin-11.64%1.27%-430.77%-1,993%-2,957%
Earning Per Share (Diluted)-0.250.02-1.38-3.43-5.10
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.0.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ